GSK gets stake in South Korea's leading drugmaker
The deal is worth 73.9 million pounds and is proof that, as sales stall in Western markets, emerging markets are the new battleground for the world’s top drugmakers.
Dong-A Pharmaceuticals is the leading pharmaceuticals and over-the-counter medicines company in South Korea, a market expected to grow around 10 percent a year through 2012.



